The use of erythropoietin and magnesium sulphate for the management of hypoxic-ischaemic encephalopathy in Lagos, Nigeria: A randomized control trial

The use of erythropoietin and magnesium sulphate for the management of hypoxic-ischaemic encephalopathy in Lagos, Nigeria: A randomized control trial

Background: Therapeutic hypothermia is the recommended treatment for moderate-to-severe hypoxic-ischemic encephalopathy (HIE) in newborns. It is not readily available in low- and middle-income countries. Newer promising interventions include erythropoietin (EPO) and magnesium sulfate (MgSO4). This s...

Full description

Saved in:
Bibliographic Details
Main Authors: Beatrice Nkolika Ezenwa, Iretiola Bamikeolu Fajolu, Gbenga Olorunfemi, Olaolu Aziza Moronkola, Zainab Opoola, Olanike Olutekunbi, Ann A. Ogbenna, Omodele Olowoyeye, Edem S. Duke, Nimota Adeyemo, Chinyere V. Ezeaka
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Journal of Clinical Sciences
Subjects:
erythropoietin
hypoxic-ischemic encephalopathy
magnesium sulfate
nigeria
outcome
randomized control trial
Online Access:https://journals.lww.com/10.4103/jcls.jcls_82_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/jcls.jcls_82_24

Similar Items